ARCH BIOPARTNERS INC (ARCH.CA) Stock Income Statement
TSX-V:ARCH - TSX Venture Exchange - CA03938C1041 - Common Stock - Currency: CAD
| TTM (2024-6-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.47M | 2.12M | 1.98M | 964.70K | 3.89M | |||
| Operating Expenses | 9.99M | 5.68M | 4.98M | 2.04M | 4.78M | |||
| Research and Development | 5.22M | 3.65M | 1.94M | 1.27M | 3.78M | |||
| Selling, General, and Administrative Expenses | 4.77M | 2.03M | 3.04M | 772.60K | 1.00M | |||
| Operating Income | -5.52M | -3.56M | -3.00M | -1.08M | -891.50K | |||
| Interest Income/Expense | -620.60K | -369.40K | -330.50K | -327.80K | -278.20K | |||
| Other Income/Expense | N/A | 6.80K | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -6.14M | -3.92M | -3.33M | -1.41M | -1.17M | |||
| Net Income | -6.14M | -3.92M | -3.33M | -1.41M | -1.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.10 | -0.06 | -0.05 | -0.02 | -0.02 | |||
| Non GAAP EPS | N/A | N/A | -0.05 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -137.55% | -184.76% | -167.71% | -145.94% | -30.10% | |||
| Operating Profit Margin | -123.65% | -167.67% | -151.05% | -111.95% | -22.94% | |||
All data in CAD